Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bowman Consulting (BWMN) Cash & Equivalents (2020 - 2025)

Bowman Consulting (BWMN) has disclosed Cash & Equivalents for 6 consecutive years, with $11.1 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 65.21% to $11.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.1 million through Dec 2025, up 65.21% year-over-year, with the annual reading at $11.1 million for FY2025, 65.21% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $11.1 million at Bowman Consulting, down from $16.2 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $38.7 million in Q3 2021, with the low at $319000.0 in Q1 2021.
  • Average Cash & Equivalents over 5 years is $18.1 million, with a median of $15.0 million recorded in 2023.
  • The sharpest move saw Cash & Equivalents soared 10852.35% in 2022, then plummeted 67.62% in 2024.
  • Over 5 years, Cash & Equivalents stood at $20.6 million in 2021, then tumbled by 35.58% to $13.3 million in 2022, then soared by 55.75% to $20.7 million in 2023, then tumbled by 67.62% to $6.7 million in 2024, then soared by 65.21% to $11.1 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $11.1 million, $16.2 million, and $15.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.